News &amp; Updates

The experimental combination of tetrahydrocannabinol (THC) plus cannabidiol (CBD) proves beneficial in reducing agitation in hospice care-eligible patients with late-stage dementia, according to the phase II LiBBY trial.

Cannabinoid combination quells agitation in late-stage dementia patients

Ageing population drives healthcare expenditure in SG

An ageing population and increasing clinical complexity are both propelling the rise in expenditure and utilization of healthcare in Singapore, a study has found.

Ageing population drives healthcare expenditure in SG

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

Patients with recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer (LG-IR-NMIBC) who achieved an initial complete response (CR) to UGN-102 treatment tend to remain event-free 24 months later, according to phase III ENVISION trial.

Noninvasive UGN-102 therapy delivers durable response in recurrent LG-IR-NMIBC

05 Aug 2026

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients

Treatment with standard ceftriaxone dose delivers adequate target attainment at low minimum inhibitory concentrations (MICs) in hospitalized patients with suspected sepsis, according to a Thai study.

Standard ceftriaxone achieves target at low MICs in suspected sepsis patients

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

In the real-world treatment of patients with obesity and type 2 diabetes, the probability of achieving combined weight and glycaemic targets is higher with sleeve gastrectomy than with either tirzepatide or semaglutide, according to a retrospective cohort study.

Sleeve gastrectomy bests incretin-based therapies for obesity, type 2 diabetes

SMA treatment with risdiplam: Experience in HK

Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder that causes progressive muscle weakness and wasting, resulting in loss of motor function. The oral drug risdiplam demonstrated improvement or stabilization of motor function in clinical studies of patients with SMA. Professor Sophelia Chan of the Department of Paediatrics and Adolescent Medicine, University of Hong Kong, shared the latest published local findings on treatment outcomes with risdiplam in paediatric and adult patients with SMA.

SMA treatment with risdiplam: Experience in HK

Prenatal ADHD medication use does not harm early developmental outcomes in offspring

Children born to mothers with attention deficit/hyperactivity disorder (ADHD) who used associated medications during pregnancy do not seem to have adverse early childhood development, according to a retrospective study from the Netherlands.

Prenatal ADHD medication use does not harm early developmental outcomes in offspring

Physical activity promotes long-term brain health

04 Aug 2026 by

Engaging in high levels of physical activity throughout adulthood may reduce the risk of dementia and preserve cognitive health.

Physical activity promotes long-term brain health

Candesartan shows promise as first-line treatment for migraine

Use of candesartan is both safe and effective, showing promise in the prevention of migraine headaches, suggests a study in the Philippines.

Candesartan shows promise as first-line treatment for migraine